Bioharvest Sciences (BHST) Operating Leases (2023 - 2025)

Bioharvest Sciences' Operating Leases history runs 3 years deep, the most recent figure standing at $1.4 million for Q4 2025.

• On a quarterly basis, Operating Leases rose 81.99% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 81.99% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 81.99% from the prior year.
• Operating Leases fell to $1.4 million in Q4 2025 per BHST's latest filing, from $9.9 million in the prior quarter.
• Across five years, Operating Leases topped out at $9.9 million in Q3 2025 and bottomed at $772000.0 in Q4 2024.
• The 3-year median for Operating Leases is $1.8 million (2023), against an average of $4.9 million.
• Biggest YoY gain for Operating Leases was 81.99% in 2025; the steepest drop was 88.44% in 2025.
• Year by year, Operating Leases stood at $1.8 million in 2023, then slumped by 57.28% to $772000.0 in 2024, then surged by 81.99% to $1.4 million in 2025.
• Per Business Quant, the three latest BHST Operating Leases figures stand at $1.4 million (Q4 2025), $9.9 million (Q3 2025), and $1.5 million (Q2 2025).